A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 11, 2003, Pages 5119-5126

  Zhang, Xun ^a   Zhou, Yunli ^a   Mehta, Kshama R ^a,b   Danila, Daniel C ^a   Scolavino, Staci ^a   Johnson, Stacey R ^a   Klibanski, Anne ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GONADOTROPIN;

ANALYTIC METHOD; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL STRAIN MCF 7; CHROMOSOME 14Q; COMPARATIVE STUDY; CONTROLLED STUDY; FUNCTIONAL ASSESSMENT; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS; HYPOPHYSIS ADENOMA; MATERNAL IMPRINTING GENE 3; MENINGIOMA; MOLECULAR CLONING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE; TUMOR CELL; TUMOR SUPPRESSOR GENE;

ADENOMA; BASE SEQUENCE; BREAST NEOPLASMS; CELL DIVISION; CLONING, MOLECULAR; DNA, COMPLEMENTARY; GENES, TUMOR SUPPRESSOR; GLIOMA; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PITUITARY NEOPLASMS; PROTEINS;

MINK CELL FOCUS-FORMING VIRUS; STAPHYLOCOCCUS PHAGE 3A;

EID: 0345172377     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030222     Document Type: Article

References (41)

1. Kontogeorgos G, Kovacs K, Horvath E, Scheithauer BW 1991 Multiple adenomas of the human pituitary. A retrospective autopsy study with clinical implications. J Neurosurg 74:243-247
2. Molitch ME, Russell EJ 1990 The pituitary "incidentaloma." Ann Intern Med 112:925-931
3. Klibanski A, Zervas NT 1991 Diagnosis and management of hormone-secreting pituitary adenomas. N Engl J Med 324:822-831
4. Alexander JM, Biller BM, Bikkal H, Zervas NT, Arnold A, Klibanski A 1990 Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest 86:336-340
5. Biller BM, Alexander JM, Zervas NT, Hedley-Whyte ET, Arnold A, Klibanski A 1992 Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. J Clin Endocrinol Metab 75:1303-1309
6. Herman V, Drazin NZ, Gonsky R, Melmed S 1993 Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab 77:50-55
7. Shimon I, Melmed S 1997 Genetic basis of endocrine disease: pituitary tumor pathogenesis. J Clin Endocrinol Metab 82:1675-1681
8. Asa SL, Ezzat S 1998 The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19:798-827
9. Faglia G, Spada A 2001 Genesis of pituitary adenomas: state of the art. J Neurooncol 54:95-110
10. Pei L, Melmed S 1997 Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 11:433-441
11. Dominguez A, Ramos-Morales F, Romero F, Rios RM, Dreyfus F, Tortolero M, Pintor-Toro JA 1998 hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG. Oncogene 17:2187-2193
12. Zhang X, Horwitz GA, Prezant TR, Valentini A, Nakashima M, Bronstein MD, Melmed S 1999 Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol 13:156-166
13. Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD, Melmed S 1999 Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84:761-767
14. Saez C, Japon MA, Ramos-Morales F, Romero F, Segura DI, Tortolero M, Pintor-Toro JA 1999 hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene 18:5473-5476
15. Zhang X, Sun H, Danila DC, Johnson SR, Zhou Y, Swearingen B, Klibanski A 2002 Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab 87:1262-1267
16. Miyoshi N, Wagatsuma H, Wakana S, Shiroishi T, Nomura M, Aisaka K, Kohda T, Surani MA, Kaneko-Ishino T, Ishino F 2000 Identification of an imprinting gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chrmosome 12 and human chromosome 14q. Genes Cells 5:211-220
17. Zhang X, Danila DC, Katai M, Swearingen B, Klibanski A 1999 Expression of prolactin-releasing peptide and its receptor messenger ribonucleic acid in normal human pituitary and pituitary adenomas. J Clin Endocrinol Metab 84:4652-4655
18. Danila DC, Zhang X, Zhou Y, Dickersin GR, Fletcher JA, Hedley-Whyte ET, Selig MK, Johnson SR, Klibanski A 2000 A human pituitary tumor-derived folliculostellate cell line. J Clin Endocrinol Metab 85:1180-1187
19. Takekawa M, Saito H 1998 A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95:521-530
20. Zhang W, Bae I, Krishnaraju K, Azam N, Fan W, Smith K, Hoffman B, Liebermann DA 1999 CR6: A third member in the MyD118 and Gadd45 gene family which functions in negative growth control. Oncogene 18:4899-4907
21. 1acZ, an insertional mutation on mouse chromosome 12 with parental origin-dependent phenotype. Mamm Genome 7:20-24
22. Schmidt JV, Matteson PG, Jones BK, Guan XJ, Tilghman SM 2000 The Dlk1 and Gtl2 genes are linked and reciprocally imprinted. Genes Dev 14:1997-2002
23. Takada S, Tevendale M, Baker J, Georgiades P, Campbell E, Freeman T, Johnson MH, Paulsen M, Ferguson-Smith AC 2000 Delta-like and gtl2 are reciprocally expressed, differentially methylated linked imprinted genes on mouse chromosome 12. Curr Biol 10:1135-1138
24. Wylie AA, Murphy SK, Orton TC, Jirtle RL 2000 Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation. Genome Res 10:1711-1718
25. Kobayashi S, Wagatsuma H, Ono R, Ichikawa H, Yamazaki M, Tashiro H, Aisaka K, Miyoshi N, Kohda T, Ogura A, Ohki M, Kaneko-Ishino T, Ishino F 2000 Mouse Peg9/Dlk1 and human PEG9/DLK1 are paternally expressed imprinted genes closely located to the maternally expressed imprinted genes: mouse Meg3/Gtl2 and human MEG3. Genes Cells 5:1029-1037
26. Lee YL, Helman L, Hoffman T, Laborda J 1995 dlk, pG2 and Pref-1 mRNAs encode similar proteins belonging to the EGF-like superfamily. Identification of polymorphic variants of this RNA. Biochim Biophys Acta 1261:223-232
27. Lendahl U 1998 A growing family of Notch ligands. Bioessays 20:103-107
28. Bauer SR, Ruiz-Hidalgo MJ, Rudikoff EK, Goldstein J, Laborda J 1998 Modulated expression of the epidermal growth factor-like homeotic protein dlk influences stromal-cell-pre-B-cell interactions, stromal cell adipogenesis, and pre-B-cell interleukin-7 requirements. Mol Cell Biol 18:5247-5255
29. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe de Angelis M, Lendahl U, Edlund H 1999 Notch signalling controls pancreatic cell differentiation. Nature 400:877-881
30. Garces C, Ruiz-Hidalgo MJ, Bonvini E, Goldstein J, Laborda J 1999 Adipocyte differentiation is modulated by secreted delta-like (dlk) variants and requires the expression of membrane-associated dlk. Differentiation 64:103-114
31. Han W, Ye Q, Moore MA 2000 A soluble form of human delta-like-1 inhibits differentiation of hematopoietic progenitor cells. Blood 95:1616-1625
32. Ohno N, Izawa A, Hattori M, Kageyama R, Sudo T 2001 dlk inhibits stem cell factor-induced colony formation of murine hematopoietic progenitors: Hes1-independent effect. Stem Cells 19:71-79
33. Carlsson C, Tornehave D, Lindberg K, Galante P, Billestrup N, Michelsen B, Larsson LI, Nielsen JH 1997 Growth hormone and prolactin stimulate the expression of rat preadipocyte factor-1/delta-like protein in pancreatic islets: molecular cloning and expression pattern during development and growth of the endocrine pancreas. Endocrinology 138:3940-3948
34. Schuster-Gossler K, Bilinski P, Sado T, Ferguson-Smith A, Gossler A 1998 The mouse Gtl2 gene is differentially expressed during embryonic development, encoding multiple alternatively spliced transcripts, and may act as an RNA. Dev Dyn 212:214-218
35. Schneider BF, Shashi V, von Kap-herr C, Golden WL 1995 Loss of chromosomes 22 and 14 in the malignant progression of meningiomas. A comparative study of fluorescence in situ hybridization (FISH) and standard cytogenetic analysis. Cancer Genet Cytogenet 85:101-104
36. Simon M, von Deimling A, Larson JJ, Wellenreuther R, Kaskel P, Waha A, Warnick RE, Tew Jr JM, Menon AG 1995 Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 55:4696-5701
37. Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P 1997 Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94:14719-14724
38. Menon AG, Rutter JL, von Sattel JP, Synder H, Murdoch C, Blumenfeld A, Martuza RL, von Deimling A, Gusella JF, Houseal TW 1997 Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative "tumor progression" locus. Oncogene 14:611-616
39. Tse JY, Ng HK, Lau KM, Lo KW, Poon WS, Huang DP 1997 Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas. Hum Pathol 28:779-785
40. Leone PE, Bello MJ, de Campos JM, Vaquero J, Sarasa JL, Pestana A, Rey JA 1999 NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Oncogene 18:2231-2239
41. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ 2000 Meningiomas. In: Kleihues PCW, ed. Pathology and genetics of tumours of the nervous system. Lyon, France: IARC Press; 176-184